TMS Co., Ltd. (TYO:4891)

Japan flag Japan · Delayed Price · Currency is JPY
140.00
+2.00 (1.45%)
At close: Mar 27, 2026
Market Cap6.37B -24.8%
Revenue (ttm)n/a
Net Income-700.90M
EPS-15.99
Shares Out45.49M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume125,100
Average Volume440,295
Open136.00
Previous Close138.00
Day's Range136.00 - 142.00
52-Week Range120.00 - 185.00
Beta0.34
RSI45.70
Earnings DateApr 10, 2026

About TMS Co., Ltd.

TMS Co., Ltd. engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities. The company is developing TMS-007, a stachybotrys microspora triprenyl phenol (SMTP) congener with prothrombolytic and anti-inflammatory/antioxidative activities, which has completed Phase 2a clinical trials for acute ischemic stroke treatment; and TMS-008, an SMTP congener with anti-inflammatory/antioxidative activities under nonclinical development for inflammatory complications... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 18
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4891
Full Company Profile

Financial Performance

Financial Statements